PP
MEDP icon

Paloma Partners’s Medpace MEDP Stock Holding History

Paloma Partners’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,434
Closed -$479K – 764
2024
Q3 		$479K Buy
+1,434
New +$545K 0.01% 637
2022
Q2 		– Sell
-2,083
Closed -$341K – 1481
2022
Q1 		$341K Sell
2,083
-563
-21% -$92.8K 0.01% 1063
2021
Q4 		$576K Buy
+2,646
New +$554K 0.01% 1036
2021
Q2 		– Sell
-1,227
Closed -$201K – 2069
2021
Q1 		$201K Buy
+1,227
New +$188K ﹤0.01% 1778
2020
Q4 		– Sell
-6,817
Closed -$762K – 2000
2020
Q3 		$762K Buy
+6,817
New +$788K 0.02% 902
2019
Q4 		– Sell
-3,068
Closed -$258K – 2366
2019
Q3 		$258K Buy
+3,068
New +$232K 0.01% 1622

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Paloma Partners's MEDP Position: Q4 2024 in Review

Paloma Partners sold out of Medpace (MEDP) in Q4 2024, closing a stake of 1,434 shares — an estimated $479K sold.

Paloma Partners first reported a position in MEDP in Q3 2019 and held it in 6 quarters. The position peaked at $762K in Q3 2020. 592 funds tracked by Wall St. Rank hold MEDP as of Q4 2024.

  • Paloma Partners reported no remaining Medpace position as of Q4 2024 after selling out during the quarter.
  • Paloma Partners sold 1,434 Medpace shares in Q4 2024, an estimated $479K.
  • Paloma Partners first reported a position in Medpace in Q3 2019 and held it in 6 quarters.
  • Paloma Partners's Medpace position peaked at $762K in Q3 2020.
  • 592 funds tracked by Wall St. Rank held Medpace as of Q4 2024.

Based on Paloma Partners's 13F filing for Q4 2024, filed 14 Feb 2025.